Cell and gene therapy's protein expression system demand — the extraordinary commercial development of viral vector-based gene therapies (AAV, lentiviral, adenoviral), CAR-T cell therapies, and mRNA therapeutics — creating novel protein expression system requirements that go beyond traditional recombinant protein manufacturing toward production of viral capsid proteins, envelope...